ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0851

Application of a Modified Recursive Feature Elimination Machine Learning Algorithm to Select Predictors of Mortality in Those with and Without Osteoarthritis

Siyeon Kim1, Siqi Xiang1, Liubov Arbeeva1, Carolina Alvarez1, Amanda Nelson1, Yvonne Golightly1, Leigh Callahan2, Michael Kosorok1 and Becki Cleveland3, 1University of North Carolina at Chapel Hill, Chapel Hill, NC, 2University of North Carolina Thurston Arthritis Research Center, Chapel Hill, NC, 3Thurston Arthritis Research Center, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC

Meeting: ACR Convergence 2021

Keywords: Epidemiology, Mortality, Osteoarthritis, risk factors, Statistical methods

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 7, 2021

Title: Research Methodology Poster (0846–0854)

Session Type: Poster Session B

Session Time: 8:30AM-10:30AM

Background/Purpose: Radiographic osteoarthritis (rOA) and joint symptoms at the knee and hip are predictors of mortality. However, questions remain about the nature of the relationship and if there are other predictors, or combinations of predictors, that contribute to increased mortality. Since non-steroidal anti-inflammatory drugs (NSAIDs) have been shown to increase risk of death and are widely used by those with OA, we applied novel statistical methods to identify a set of predictors of mortality, and whether these predictors interact with NSAID use

Methods: Data were from 4,156 participants in the Johnston County Osteoarthritis Project (JoCoOA), a longitudinal community-based cohort of Black and White men and women aged ≥45 years. Vital status was assessed using the National Death Index records to capture date of death through December 2015. Clinical exams, radiographs and questionnaires were completed at baseline and at up to 3 follow-up time points. Socio-demographic and clinical characteristics, including comorbidities and joint symptoms, were considered as predictors and NSAID use was considered as an effect modifier. Multiple imputation was used for missing data.

We applied a time-varying covariate stratified cox model with recursive feature elimination (RFE). RFE searches for a subset of predictors starting with a full model including all predictors in the training dataset, and successively removing one at a time. Our model initially included 57 predictors, with NSAID use entered as an interaction term with all other predictors. A model with the smallest change in log-likelihood from the full model was selected and that predictor, along with its interaction with NSAID use, was dropped. This process was repeated until no predictors remained in the model. Using a plot of the log-likelihoods after each elimination, the final model was selected based on an inflection point prior to a notable decrease in log-likelihood (Figure 1). All observations were stratified by the time point, and hazard ratios (HR) and 95% confidence intervals (CI) were estimated.

Results: Mean age of the participants at baseline was 61 years, 63% were female and 66% were white (Table 1). More than 34% of participants reported taking NSAIDs at baseline, which increased to 51%, 67%, and 70% at the first, second, and third follow-up, respectively, over which time 1,812 deaths occurred.

In the RFE model, we found that after iterative predictor elimination, 13 predictors showed an important contribution to excess death (Figure 1, Table 2). The strongest contributors were current smoking status, cancer, diabetes and male sex. Left knee pain was associated with a 19% increased HR. We observed an NSAID-modified association with right knee injury where those with a knee injury and no NSAID use had a 30% lower hazard of mortality, whereas little association was observed for right knee injury among those who used NSAIDs.

Conclusion: We show that an application of a RFE algorithm is useful to both select the important predictors, and to quantify predictive validity, on excess mortality. The model demonstrated good performance in selecting a set of predictors and identifying characteristics most important in premature death that can be explored in future analyses.

Table 1. Demographic characteristics over study visits, JoCoOA Study

Table 2. Final prediction model

Figure 1. Plot of Log-likelihood values by number of variables dropped in each iteration indicating inflection points


Disclosures: S. Kim, None; S. Xiang, None; L. Arbeeva, None; C. Alvarez, None; A. Nelson, Lilly, 1; Y. Golightly, None; L. Callahan, None; M. Kosorok, None; B. Cleveland, None.

To cite this abstract in AMA style:

Kim S, Xiang S, Arbeeva L, Alvarez C, Nelson A, Golightly Y, Callahan L, Kosorok M, Cleveland B. Application of a Modified Recursive Feature Elimination Machine Learning Algorithm to Select Predictors of Mortality in Those with and Without Osteoarthritis [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/application-of-a-modified-recursive-feature-elimination-machine-learning-algorithm-to-select-predictors-of-mortality-in-those-with-and-without-osteoarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/application-of-a-modified-recursive-feature-elimination-machine-learning-algorithm-to-select-predictors-of-mortality-in-those-with-and-without-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology